TCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial By Cancer History Project October 31, 2014
TCL Archive The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power By Cancer History Project October 31, 2014
TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease By Cancer History Project October 31, 2014
TCL Archive Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever By Cancer History Project October 31, 2014
TCL Archive FDA Approves Velcade Injection In Mantle Cell Lymphoma By Cancer History Project October 31, 2014
TCL Archive Bennett, Federal Prosecutors Reach $475,000 Settlement By Cancer History Project October 31, 2014
TCL Archive Phase II Study of Veliparib Improves PFS by 35 Percent By Cancer History Project October 31, 2014
TCL Archive Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program By Cancer History Project October 31, 2014
